Products

Methylprednisolon Cortico 4 mg tablets

Subgroup: Glucocorticoids

Medical product subject to medical prescription

Route (s) of administration: Oral use

Nature and contents of container: 10 tablets are packed in a blister of PVC/aluminium foil.
2 blisters with package leaflet: information for the user in a carton box
100 tablets are packed in a nontransparent plastic container with closure system “cap-in-cap” with locking ring. One container is packed in a carton box.

Prescriptions:

Corticosteroids are intended for symptomatic treatment excluding some endocrine diseases, in which they are used for substitution.
Methylprednisolon Cortico is used for the treatment of:
Non-endocrine diseases:
   • Rheumatic Disorders
As adjunctive therapy in maintenance therapy or for short-term administration (to tide the patient over an acute episode or exacerbation) in psoriatic arthritis, rheumatoid arthritis, including juvenile rheumatoid arthritis, ankylosing spondylitis, acute and subacute bursitis, acute nonspecific tenosynovitis, acute gouty arthritis, post-traumatic osteoarthritis, synovitis of osteoarthritis, epicondylitis,
   • Collagen Diseases
During an exacerbation or as maintenance therapy in selected cases of: Systemic lupus erythematosus, systemic dermatomyositis (polymyositis), acute rheumatic carditis, giant cells arthritis,
   • Dermatologic Diseases
Pemphigus vulgaris, bullous dermatitis herpetiformis, erythema multiforme, exfoliative dermatitis mycosis fungoides, severe psoriasis vulgaris, severe seborrheic dermatitis,
   • Allergic States
Control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment, such as: Seasonal or perennial allergic rhinitis, serum sickness, bronchial asthma, drug hypersensitivity reactions, contact dermatitis, atopic dermatitis,
   • Ophthalmic Diseases
Severe acute and chronic allergic and inflammatory processes involving the eye and its adnexa, such as: Allergic corneal marginal ulcers, herpes zoster ophthalmicus, anterior segment inflammation, diffuse posterior uveitis and choroiditis, ophthalmia sympatica, allergic conjunctivitis, keratitis, chorioretinitis, optic neuritis, iritis and iridocyclitis,
   • Respiratory Diseases
Sarcoidosis, Loeffler's syndrome not manageable by other means, berylliosis, fulminating or disseminated pulmonary tuberculosis (when used concurrently with appropriate antituberculous chemotherapy), aspiration pneumonitis,
   • Hematologic Disorders
Idiopathic thrombocytopenic purpura in adults, secondary thrombocytopenia in adults, acquired hemolytic anemia, erythroblastopenia, congenital hypoplastic anemia,
   • Neoplastic Diseases
For palliative management of: Leukemias and lymphomas in adults, acute leukemia of childhood,
   • Edematous States
To induce a diuresis or remission of proteinuria in the nephrotic syndrome, without uremia, of the idiopathic type or that due to lupus erythematosus,
   • Gastrointestinal Diseases
To overcome a critical period of the disease in: Ulcerative colitis and in Crohn disease,
   • Nervous System
Acute exacerbations of multiple sclerosis, edema in case of brain tumor,
   • Miscellaneous
Tuberculous meningitis with subarachnoid block or impending block, when used concurrently with appropriate antituberculous chemotherapy, trichinosis with neurologic or myocardial involvement,

Organ transplantation
Endocrine Disorders
Primary or secondary adrenocortical insufficiency,
Congenital adrenal hyperplasia, thyroiditis,
Hypercalcemia associated with cancer.